(1 - 12 von 12
)
Aptamer Group trades on AIM market of the London Stock ...
www.yorkpress.co.uk
— From left: Arron Tolley, CEO of Aptamer Group, with co-founder Dr David Bunka, Harriet Flynn, Joe Reed and Banushan Balansethupathy at The ... › news
Guardian: UK biotech firm Aptamer to float valued at £80.7m | Biotechnology...
York-based company makes synthetic antibodies for … firms including AstraZeneca
Monday newspaper round-up: Aptamer, household savings, hospitality
www.sharecast.com
— , an early school leaver who later completed a doctorate in biophysics and molecular biology, and Dr David Bunka, a geneticist. › news
Aptamer IPO: How to buy shares of this biotechnology firm on AIM?
kalkinemedia.com
Highlights
UK biotechnology firm, Aptamer, is all set to make a debut on LSE’s AIM sub-segment.
Over the last four years, the com...
Biotech Business raises $2.2m Investment - Labmate Online
www.labmate-online.com
Pictured back row l-r: Paul Lelieveld, Frans van Dalen, David Bunka, Arron Tolley. Front row: Steven Hull, Katie Lockwood ... › ...
Aptamer Group raises $2.2M investment - bionity.com
www.bionity.com
— Aptamer Group was founded in by Chief Executive Officer, Dr Arron Tolley and Chief Technical Officer, Dr David Bunka, who lead the now ... › news
Aptamer Group: UK Biotech Business Raises $2.2M Investment
www.b3cnewswire.com
— Aptamer Group was founded in by Chief Executive Officer, Dr Arron Tolley and Chief Technical Officer, Dr David Bunka, who lead the now ... › ...
Biotech business completes $2.2m funding round
www.insidermedia.com
— Aptamer Group was founded in by chief executive Dr Arron Tolley and chief technical officer Dr David Bunka, who lead the now 16-strong team ... › yo...
Former Earls pupil's £2.2m lifesaving device for doctors
www.dudleynews.co.uk
— Arron and his colleague David Bunka, who founded the Leeds based firm together in 2008, have won a prestigious Technology Strategy Board's ... › n...
View Aptamers Agenda | International Society on Aptamers
aptamersociety.org
— Chair Dr David Bunka : Professor Thomas Brown, University of Oxford, United Kingdom Synthesis of chemically modified oligonucleotides ... › business
£80m AIM market float imminent for life sciences group
www.thebusinessdesk.com
— Aptamer is led by cofounders Dr Arron Tolley, chief executive officer and Dr David Bunka, chief technical officer, who between them have › ...
sortiert nach Relevanz / Datum